Expression of CD23 by human bone marrow stromal cells. 1992

C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
Laboratoire d'Immunologie, CHU Pitié-Salpêtrière, Paris, France.

CD23 is a surface antigen expressed by a variety of human hematopoietic cells and shown to display multiple biological functions. In present work, we assayed CD23 expression by human bone marrow (BM) or by stromal cells derived from this tissue. While freshly isolated BM-cells showed low CD23 expression, a subset of long term BM-culture (LTBMC)-derived stromal cells expressed CD23 mRNA at high levels in their steady state and secreted soluble CD23 in their culture supernatants. To assay the role of CD23 in LTBMC, these cultures were initiated in the presence of neutralizing anti-CD23 mAb. A dramatic decrease in total numbers of hematopoietic cells and CFU-GM recovery was observed in these cultures as compared to controls. These data suggest a role of CD23 expression in stroma cell functions and further confirm the ability of this antigen to regulate human hematopoietic cell development.

UI MeSH Term Description Entries
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D017403 In Situ Hybridization A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes. Hybridization in Situ,Hybridization, In Situ,Hybridizations, In Situ,In Situ Hybridizations
D017455 Receptors, IgE Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI). Antigens, CD23,CD23 Antigens,Fc Receptors, epsilon,Fc epsilon Receptor,Fc epsilon Receptors,IgE Receptor,IgE Receptors,Receptors, Fc epsilon,epsilon Fc Receptor,epsilon Fc Receptors,CD 23 Antigens,CD23 Antigen,Fc epsilon RI,Fc epsilon RII,Immunoglobulin E Receptor,Antigen, CD23,Antigens, CD 23,Fc Receptor, epsilon,Receptor, Fc epsilon,Receptor, IgE,Receptor, Immunoglobulin E,Receptor, epsilon Fc,Receptors, epsilon Fc,epsilon RI, Fc,epsilon RII, Fc,epsilon Receptor, Fc,epsilon Receptors, Fc
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
January 2004, Experimental neurology,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
February 1994, Leukemia,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
June 2002, Nature biotechnology,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
July 2008, Journal of tissue engineering and regenerative medicine,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
December 1998, Journal of cellular physiology,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
August 2017, BMC genomics,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
January 2001, Journal of cellular biochemistry,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
February 2002, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
June 1996, Leukemia,
C Fourcade, and M Arock, and S Ktorza, and F Ouaaz, and H Merle-Béral, and F Mentz, and E Kilchherr, and P Debré, and M D Mossalayi
February 1998, Biochemical Society transactions,
Copied contents to your clipboard!